apollo
logo
0Login
Introducing Our Latest Arrival!
Cancrinase 3750 IU Injection 1's

Cancrinase 3750 IU Injection 1's

Prescription drug
 Trailing icon
Consult Doctor

Synonym

PEG L ASPARAGINASE

Manufacturer/Marketer

Mankind Pharma Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-26

for this medicine

About Cancrinase 3750 IU Injection

Cancrinase 3750 IU Injection is used in the treatment of acute lymphoblastic leukaemia (ALL). It is also used with other chemotherapy drugs to treat a certain type of ALL in people who have had allergic reactions to medications similar to pegaspargase, such as asparaginase.

Cancrinase 3750 IU Injection contains Pegaspargase, an enzyme that breaks down asparagine, an important building block of proteins without which cells cannot survive. Cancrinase 3750 IU Injection lowers the asparagine levels in blood cancer cells and stops the cancer cells from growing.

In some cases, Cancrinase 3750 IU Injection may cause side effects such as tiredness, dizziness, fever, nausea, vomiting, and diarrhoea. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with the doctor if any of the side effects persist or worsen.

Do not receive Cancrinase 3750 IU Injection if you are pregnant or breastfeeding. Avoid driving or using machines as Cancrinase 3750 IU Injection may cause drowsiness, tiredness, and confusion. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Uses of Cancrinase 3750 IU Injection

Treatment of Acute lymphoblastic leukaemia (ALL)

Medicinal Benefits

Cancrinase 3750 IU Injection is used to treat acute lymphoblastic leukaemia (ALL). It is also used with other chemotherapy drugs to treat a certain type of ALL in people who have had allergic reactions to medications similar to pegaspargase, such as asparaginase. Cancrinase 3750 IU Injection contains Pegaspargase, an enzyme that breaks down asparagine, an important building block of proteins without which cells cannot survive. Normal cells can make asparagine for themselves, while some cancer cells cannot. Cancrinase 3750 IU Injection lowers asparagine levels in blood cancer cells and stops the cancer cells from growing.

Directions for Use

Cancrinase 3750 IU Injection will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Cancrinase 3750 IU Injection

  • Nausea
  • Vomiting
  • Fever
  • Diarrhoea
  • Tiredness
  • Dizziness

Drug Warnings

Do not use Cancrinase 3750 IU Injection if you are allergic to any of its components if you have severe liver disease, pancreatitis (inflammation of the pancreas) or if you have ever had severe bleeding or blood clots following asparaginase therapy. Inform the doctor if you have had serious allergic reactions to other forms of asparaginase, if you suffer from a bleeding disorder or have had serious blood clots, if you get a fever if you have poor liver function, diabetes, stroke or abdominal pain. Seek medical attention if you experience symptoms of osteonecrosis (pain in the knee, back or hip), liver or pancreas problems (loss of appetite, upper stomach pain, nausea or vomiting, fast heart rate, dark urine, or yellowing of the skin or eyes), low blood cell count (fever, mouth sores, skin sores, sore throat, cough, trouble breathing), blood clot (sudden numbness or weakness, problems with vision or speech, swelling or redness in an arm or leg), high blood sugar (increased thirst, increased urination, dry mouth, fruity breath odour) or if you notice unusual bleeding, easy bruising, or purple/red spot under the skin.

Drug Interactions

Drug-Drug Interactions: Inform the doctor if you are taking anticoagulants (warfarin, heparin, dipyridamole, aspirin), live vaccines, anti-cancer (methotrexate, cytarabine), glucocorticoids, steroids (prednisolone), or pain killers (ibuprofen, naproxen). 

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Inform the doctor if you have severe liver disease, inflammation of the pancreas, bleeding disorders, or diabetes.

Drug-Drug Interactions Checker List

  • WARFARIN
  • HEPARIN
  • DIPYRIDAMOLE
  • ASPIRIN
  • METHOTREXATE
  • CYTARABINE
  • PREDNISOLONE
  • IBUPROFEN
  • NAPROXEN

Habit Forming

No

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include vegetables and fruits in your diet.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugar.
  • Get optimal sleep; rest well.
  • Drink enough water and eat fibre-rich foods, vegetables and fruits.

Special Advise

  • Women of reproductive potential must use reliable contraception during treatment with Cancrinase 3750 IU Injection and for six months after the last dose.
  • Men should use effective contraception while they or their partners are on treatment with Cancrinase 3750 IU Injection.
  • Your doctor may advise tests for monitoring blood and urine sugar levels, as well as liver and pancreatic function.
  • If you are undergoing immunisation with live vaccines, inform the doctor.

Disease/Condition Glossary

Acute lymphoblastic leukaemia (ALL): ALL is a white blood cell cancer in which certain immature white cells called lymphoblasts start growing out of control, thus preventing the production of functional blood cells. It occurs when an error develops in the bone marrow cell. Symptoms include bruising, enlarged lymph nodes, bone pain, fever, frequent infections, and bleeding from the gums.

bannner image

Alcohol

Caution

Please consult your doctor before consuming alcohol while on treatment with Cancrinase 3750 IU Injection as it may increase the risk of side effects such as liver damage.

bannner image

Pregnancy

Caution

Pegaspargase belongs to pregnancy category C. The effects of Cancrinase 3750 IU Injection during pregnancy have not been studied. If you are pregnant, planning for pregnancy or think you may be pregnant, talk to the doctor for advice.

bannner image

Breast Feeding

Unsafe

It is not known if Pegaspargase passes into breast milk. As a precautionary measure, breastfeeding should be discontinued during treatment and should not be re-started until after treatment with Cancrinase 3750 IU Injection has been discontinued.

bannner image

Driving

Caution

Do not drive or operate machinery as Cancrinase 3750 IU Injection may cause tiredness, confusion, and drowsiness.

bannner image

Liver

Caution

Cancrinase 3750 IU Injection is not recommended if you have severe liver disease. If you have a history of liver disease, inform your doctor before receiving Cancrinase 3750 IU Injection.

bannner image

Kidney

Consult your doctor

If you have a history of kidney disease, inform your doctor before receiving Cancrinase 3750 IU Injection.

bannner image

Children

Safe if prescribed

Cancrinase 3750 IU Injection is safe for use in children if prescribed by the doctor.

Country of origin

India

Manufacturer/Marketer address

208, Okhla Industrial Estate, Phase Iii, New Delhi -.
Other Info - CAN0741

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Cancrinase 3750 IU Injection is used to treat Acute lymphoblastic leukaemia (ALL).
Cancrinase 3750 IU Injection works by killing or stopping the growth of cancer cells.
If anticoagulants are used at the same time as Cancrinase 3750 IU Injection, there may be a higher risk of bleeding disorders. Therefore, consult the doctor if you are taking anticoagulant/blood thinner medicines.
Oral contraceptive is not an effective method of contraception whilst on treatment with Cancrinase 3750 IU Injection. Ask your doctor about the best contraceptive to use.
Cancrinase 3750 IU Injection may cause osteonecrosis (bone damage), especially when taken concomitantly with glucocorticoids. If you experience any new bone pain, like pain in the hip, back or knee, inform the doctor as soon as possible.
Consult the doctor if you are undergoing immunisation with live vaccines within 3 months of completing the treatment, as it may increase the risk of severe infections.
Cancrinase 3750 IU Injection can lead to fluctuations in clotting factors and may increase the risk of bleeding and/or clotting. If you notice unusual bleeding or bruising, consult the doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Add to Cart